Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aridis Pharmaceuticals, Inc. | Director | Common stock purchase | 885K | $61.9K | $0.07 | Jun 24, 2024 | Direct |
Aridis Pharmaceuticals, Inc. | Director | Stock Options | 162K | Sep 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARDS | Aridis Pharmaceuticals, Inc. | Jun 24, 2024 | 1 | $50K | 4 | Jun 28, 2024 | Director |
ARDS | Aridis Pharmaceuticals, Inc. | Sep 18, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Executive Chairman, Director |
ARDS | Aridis Pharmaceuticals, Inc. | May 4, 2023 | 3 | $0 | 4 | Jun 15, 2023 | Executive Chairman, Director |
ARDS | Aridis Pharmaceuticals, Inc. | Dec 5, 2022 | 1 | $0 | 4 | Dec 7, 2022 | Executive Chairman, Director |
ARDS | Aridis Pharmaceuticals, Inc. | Jul 27, 2021 | 1 | $25K | 4 | Jul 27, 2021 | Director |